A reduction in hepatic triglyceride content by pioglitazone is associated with a decrease in plasma CETP mass, in patients with type 2 diabetes mellitus

J.T. Jonker; Y. Wang; W. de Haan; M. Diamant; L.J. Rijzewijk; R.W. van der Meer; H.J. Lamb; J.T. Tamsma; A. de Roos; J.A. Romijn; P.C.N. Rensen; J.W.A. Smit

A reduction in hepatic triglyceride content by pioglitazone is associated with a decrease in plasma CETP mass, in patients with type 2 diabetes mellitus

J.T. Jonker, Y. Wang, W. de Haan, M. Diamant, L.J. Rijzewijk, R.W. van der Meer, H.J. Lamb, J.T. Tamsma, A. de Roos, J.A. Romijn, P.C.N. Rensen, J.W.A. Smit

Internal medicine

Research output: Contribution to journal › Meeting Abstract › Other research output

Original language	Undefined/Unknown
Pages (from-to)	A285-A285
Journal	Diabetes
Volume	59
Publication status	Published - 2010

Cite this

Jonker, J. T., Wang, Y., de Haan, W., Diamant, M., Rijzewijk, L. J., van der Meer, R. W., ... Smit, J. W. A. (2010). A reduction in hepatic triglyceride content by pioglitazone is associated with a decrease in plasma CETP mass, in patients with type 2 diabetes mellitus. Diabetes, 59, A285-A285.

Jonker, J.T. ; Wang, Y. ; de Haan, W. ; Diamant, M. ; Rijzewijk, L.J. ; van der Meer, R.W. ; Lamb, H.J. ; Tamsma, J.T. ; de Roos, A. ; Romijn, J.A. ; Rensen, P.C.N. ; Smit, J.W.A. / A reduction in hepatic triglyceride content by pioglitazone is associated with a decrease in plasma CETP mass, in patients with type 2 diabetes mellitus. In: Diabetes. 2010 ; Vol. 59. pp. A285-A285.

@article{3672454348724b73a6d15916cfcb5308,

title = "A reduction in hepatic triglyceride content by pioglitazone is associated with a decrease in plasma CETP mass, in patients with type 2 diabetes mellitus",

author = "J.T. Jonker and Y. Wang and {de Haan}, W. and M. Diamant and L.J. Rijzewijk and {van der Meer}, R.W. and H.J. Lamb and J.T. Tamsma and {de Roos}, A. and J.A. Romijn and P.C.N. Rensen and J.W.A. Smit",

year = "2010",

language = "Undefined/Unknown",

volume = "59",

pages = "A285--A285",

journal = "Diabetes",

issn = "0012-1797",

publisher = "American Diabetes Association Inc.",

}

A reduction in hepatic triglyceride content by pioglitazone is associated with a decrease in plasma CETP mass, in patients with type 2 diabetes mellitus. / Jonker, J.T.; Wang, Y.; de Haan, W.; Diamant, M.; Rijzewijk, L.J.; van der Meer, R.W.; Lamb, H.J.; Tamsma, J.T.; de Roos, A.; Romijn, J.A.; Rensen, P.C.N.; Smit, J.W.A.

In: Diabetes, Vol. 59, 2010, p. A285-A285.

Research output: Contribution to journal › Meeting Abstract › Other research output

TY - JOUR

T1 - A reduction in hepatic triglyceride content by pioglitazone is associated with a decrease in plasma CETP mass, in patients with type 2 diabetes mellitus

AU - Jonker, J.T.

AU - Wang, Y.

AU - de Haan, W.

AU - Diamant, M.

AU - Rijzewijk, L.J.

AU - van der Meer, R.W.

AU - Lamb, H.J.

AU - Tamsma, J.T.

AU - de Roos, A.

AU - Romijn, J.A.

AU - Rensen, P.C.N.

AU - Smit, J.W.A.

PY - 2010

Y1 - 2010

M3 - Meeting Abstract

VL - 59

SP - A285-A285

JO - Diabetes

JF - Diabetes

SN - 0012-1797

ER -